Trade APGE anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Apogee Therapeutics, Inc. (APGE) is trading at US$135.07, up 0.00% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$10.2B. Over the past 52 weeks, APGE has traded between US$35.39 and US$135.09. On Syfe you can trade APGE with $0 commission and add it to your watchlist.
| Previous close | US$135.07 |
|---|---|
| Market cap | US$10.2B |
| 52-week range | US$35.39 – US$135.09 |
| Volume | 5.14M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Apogee Therapeutics, Inc.
Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in San Francisco, CA.
Year: 2023
Correction: --AbbVie Launches $10 Billion Bond Sale to Fund Apogee Acquisition, Bloomberg Reports
Aug 4, 6:01 PM · MT Newswires
Apogee Therapeutics, Inc. (APGE) stock is trading at US$135.07, 0.00% from the previous close of US$135.07.
The market cap for Apogee Therapeutics, Inc. (APGE) stock is approximately US$10.2B.
The 52-week high for Apogee Therapeutics, Inc. (APGE) stock is US$135.09.
The 52-week low for Apogee Therapeutics, Inc. (APGE) stock is US$35.39.
Apogee Therapeutics, Inc. (APGE) does not currently pay a dividend.
Stay on top of APGE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
